Kit ligand promotes first polar body extrusion of mouse preovulatory oocytes
© Ye et al; licensee BioMed Central Ltd. 2009
Received: 23 January 2009
Accepted: 03 April 2009
Published: 03 April 2009
Shortly after stimulation by the preovulatory surge of luteinizing hormone (LH), oocytes arrested at the late prophase I resume meiosis characterized by germinal vesicle breakdown (GVBD), chromosome condensation, and extrusion of the first polar body in preparation for fertilization and early embryonic development. However, oocytes express few or no LH receptors and are insensitive to direct LH stimulation. Thus, factors released by granulosa or theca cells expect to convey the LH stimuli to oocytes. To identify candidate ligand-receptor pairs potentially involved in the process of oocyte maturation, we performed DNA microarray analyses of ovarian transcripts in mice and identified Kit ligand (Kitl) as an ovarian factor stimulated by the LH/hCG surge. The purpose of this study is to investigate the roles of KITL in the nuclear and cytoplasmic maturation of preovulatory mouse oocytes.
The levels of Kitl and c-kit transcripts in mouse ovaries and isolated ovarian cells were determined by real-time RT-PCR, while expression of KITL protein was examined by immunohistochemistry. Follicle culture, cumulus-oocyte complexes (COC) and denuded oocytes culture were used to evaluate the effect of KITL on mouse oocyte nuclear maturation. To assess the effect of KITL treatment on the cytoplasmic maturation of preovulatory oocytes, we performed in vitro maturation of oocytes followed by in vitro fertilization.
Major increase of Kitl transcripts in granulosa cells and mouse ovaries, and predominant expression of c-kit in preovulatory oocytes were identified by real-time RT-PCR. Predominant expression of KITL protein was found in granulosa cells of preovulatory and small antral follicles at 4 h after hCG treatment. In vitro cultures demonstrated that treatment with KITL enhanced first polar body extrusion in a dose-dependent manner. Moreover, treatment of COC with KITL enhanced first polar body extrusion with increase in cyclin B1 synthesis which is important for the progression of meiotic maturation after GVBD. In contrast, treatment of cultured preovulatory follicles with KITL did not affect GVBD and KITL has no effect on cytoplasmic maturation of preovulatory oocytes.
Our findings suggest potential paracrine roles of KITL in the nuclear maturation of preovulatory oocytes by promoting first polar body extrusion.
Meiosis of mammalian oocytes is characterized by prolonged arrest at the diplotene stage of prophase I. Before ovulation, preovulatory oocytes undergo maturation. Oocyte maturation includes nuclear maturation events characterized by germinal vesicle breakdown (GVBD) and the extrusion of first polar body . In addition to nuclear maturation to complete the first meiotic division, oocytes also undergo cytoplasmic maturation characterized by cytoplasmic changes essential for monospermic fertilization, processing of the sperm, and preparation for development to preimplantation embryos [2, 3]. The preovulatory luteinizing hormone (LH) surge triggers oocytes to resume meiosis characterized by GVBD, chromosome condensation, and extrusion of the first polar body in preparation for fertilization and early embryonic development. However, oocytes express few or no LH receptors and are insensitive to direct LH stimulation. Thus, factors released by the LH-responsive granulosa or theca cells likely convey the LH stimuli to oocytes . Recent studies demonstrated that the endocrine hormone LH stimulates ovarian production of epidermal growth factor (EGF)-like factors from granulosa cells and insulin-like 3 (INSL3) from theca cells to promote GVBD [5, 6]. Preovulatory increases in LH also stimulate granulosa cells to produce brain-derived neurotrophic factor (BDNF) that is capable of promoting first polar body extrusion and the cytoplasmic maturation of oocytes .
We performed DNA microarray analyses using ovaries from immature mice following gonadotropin stimulation and identified candidate ligand-receptor pairs potentially involved in the process of oocyte maturation . Among different candidate genes, we found major increases in the ovarian expression of kit ligand (Kitl, also known as stem cell factor) during the preovulatory period. KITL is a pluripotent growth factor which is important in the differentiation and growth of diverse stem cell lineages including hematopoietic stem cells, neuroblasts, primordial germ cells, et al  and its receptor is c-kit (CD117), a receptor protein tyrosine kinase belonging to the platelet-derived growth factor receptor family . KITL and c-kit are the products of Steel (Sl) and White Spotting (W) loci in mice, respectively. Mutations in these loci will lead to infertility due to impairment of primordial germ cell survival, migration and proliferation, as well as defective follicle development . KITL exists as both soluble (KITL1) which mediates cellular migration and membrane-bound (KITL2) proteins which contributes to cell survival and proliferation. Both KITL1 and KITL2 transcripts can be detected in ovaries and recent study showed that KITL2, but not KITL1 promoted mouse oocyte growth. Although the KITL/c-kit signaling pathway is essential for diverse ovarian processes, including the initiation of primordial follicle development [11, 12], growth of oocytes in primordial and pre-antral follicles [11, 13–16], proliferation of granulosa cells , recruitment of theca cells, and the regulation of ovarian steroidogenesis [8, 14, 18, 19], few studies have explored the roles of KITL in oocyte maturation.
Here, we demonstrated preovulatory increases of KitL transcripts in ovarian granulosa and cumulus cells, but not its receptor, c-kit, which is predominantly expressed in mouse oocytes. Treatment of cultured oocytes with KITL enhanced first polar body exclusion.
Ovarian samples were obtained from immature female B6D2F1 mice at 25–27 days of age (CLEA Japan, Inc., Tokyo, Japan) after treatment with a single intraperitoneal injection of 7 IU pregnant mare serum gonadotropin (PMSG; Calbiochem, Cambridge, Massachusetts, USA), followed at 48 h later with 10 IU of human chorionic gonadotropin (hCG, ASKA Pharmaceutical, Co., Ltd, Tokyo, Japan) to stimulate follicle maturation and ovulation, respectively. The care of animals was approved by the Animal Research Committee, Akita University School of Medicine.
DNA microarray analysis
Mice (n = 108) were injected at 21 days of age with Humegon (7.5 IU per animal, Organon, Oss, Netherlands) containing FSH and LH activities to stimulate follicular growth. Forty-eight hours later, some animals were treated ip with Pregnyl (5 IU per animal, Organon) containing LH activity to induce ovulation. Ovaries were dissected from animals killed bi-hourly after Humegon treatment (three mice per group) and hourly after Pregnyl treatment (one mouse per group) for RNA extraction (TRIzol, Invitrogen Corp., Carlsbad, CA). Aliquots of 6 μg of total RNA at 1 μg/μl for one-chipset hybridization were stored at -80 C. Samples were hybridized to the Affymetrix mouse MGU74v2 arrays A, B, and C according to standard Affymetrix protocols. The pooled follicular phase samples were hybridized in duplicate, and the post Pregnyl samples were single determinations .
Quantitative real-time RT-PCR
For quantitative real-time RT-PCR, oocytes, cumulus cells, and mural granulosa cells were collected from ovaries of PMSG-primed immature mice at 48 h after treatment or from ovaries of PMSG-primed immature mice at 2 h after hCG treatment. Cumulus-oocyte complexes (COCs) were obtained by puncturing the largest follicles of preovulatory ovaries, and denuded oocytes (DOs) were separated from cumulus cells by mechanical pipetting. Granulosa cells were obtained separately by puncturing preovulatory follicles, followed by the removal of COCs.
Quantitative real-time RT-PCR of transcript levels were performed using whole ovaries and isolated ovarian cells using a Smartcycler (Takara, Tokyo, Japan) [6, 7]. The primers and hybridization probes for real-time PCR of Kitl, c-kit and histone H2a are as follow: Kitl: sense 5'-ACATGGTGGCTGCTCTTCTT-3', antisense 5'-TGCAGACCTGATAGCATTGG-3', probe 5'-6-carboxy-fluorescein (FAM)-TGGTCTCTAGTTCCTTCTCTAATGCTCTGA-carboxy-tetramethyl-rhodamine (TAMRA)-3'; c-kit: sense 5'-CGTGAACTCCATGTGGCTAA-3', antisense 5'-CGTCTCCTGGCGTTCATAAT-3', probe 5'-FAM-AAGCACAATAGCTGGCACCGG-TAMRA-3'; histone H2a: sense 5'-ACGAGGAGCTCAACAAGCTG-3', antisense 5'-TATGGTGGCTCTCCGTCTTC-3', probe 5'-FAM-AACATCCAGGCCGTGCTGCT-TAMRA-3'. To determine the copy number of target transcripts, cloned plasmid cDNAs for individual genes were used to generate a calibration curve. Purified plasmid cDNA templates were measured, and copy numbers were calculated based on absorbance at 260 nm. A calibration curve was created by plotting the threshold cycle against the known copy number for each plasmid template diluted in log steps from 106 to 101 copies. Each run included diluted plasmids to generate a calibration curve, a negative control without a template, and samples with unknown mRNA concentrations. Data were normalized based on histone H2a transcript levels.
To localize KITL, ovaries were obtained from PMSG-primed mice at 4 h after hCG treatment. After fixation with 10% neutral formalin (pH 7.4) for 24 h, tissues were embedded in paraffin and sectioned at 6-μm intervals. After de-paraffinization and dehydration, endogenous peroxidase activities were quenched with 0.3% hydrogen peroxidase-methanol for 30 min. After blocking with 10% BSA-PBS for 30 min, slides were then incubated with goat anti-KITL antibodies characterized previously (R&D system, Minneapolis, Minnesota, USA) at 1:200 dilution overnight at 4 C. After three washes in Tris-buffered saline (TBS), slides were incubated with biotinylated anti-goat secondary antibodies (Nichirei Bioscience, Tokyo, Japan) for 30 min at room temperature. After three washes, bound antibodies were visualized using a DAB kit (DAKO Corp., Carpinteria, California, USA) and tissues were counterstained with hematoxylin. For negative controls, the primary antibodies were replaced by nonimmune goat IgG (DAKO Corp.).
Preovulatory follicles were excised from mouse ovaries at 48 h after PMSG treatment and cultured to examine nuclear maturation of oocytes . Follicles (15–20 per vial) were treated with or without recombinant murine KITL (Peprotech Inc., Rocky Hill) or epidermal growth factor (EGF) (positive control, Sigma, St. Louis, MO) in Leibovitz's L-15 medium (Invitrogen). The vials were flushed at the start of the culture with O2/N2 (at a 1:1 ratio), sealed, and cultured at 37 C with gentle shaking for 8 h. After culture, COCs were isolated, and, after cumulus cell removal, oocytes are examined for the occurrence of GVBD under a Hoffman contrast microscopy (Nikon Inc., Tokyo, Japan).
Evaluation of first polar body extrusion
Either COCs or DOs were cultured with or without KITL to evaluate the effect of KITL on the transition from metaphase I (MI) stage to metaphase II (MII) stage oocytes. The doses of KITL for the present studies were based on the levels of KITL in human follicular fluid (560–660 pg/ml) and those of other ovarian paracrine factors used in oocyte maturation studies[5, 7]. COCs and DOs were obtained from mouse ovaries at 48 h after PMSG-treatment following isolation of preovulatory follicles and puncturing of the largest follicles as described above. After washing, COCs or DOs were transferred to M16 medium (Sigma) without FBS, and cultured with or without KITL for 24 h at 37 C in 5% CO2 95% air. Some COCs were cultured with KITL with or without a neutralizing goat anti-mouse KITL antibody (R&D system). The occurrence of first polar body extrusion in the oocytes was examined after removing cumulus cells by using a small-bore pipette.
COC cultures and immunoblotting analyses
COCs were cultured with or without KITL to measure the levels of cyclin B1 in oocytes by immunoblotting. COCs were obtained from mouse ovaries at 48 h after PMSG treatment and cultured with or without 5 ng/ml KITL as described above. After 7 h of treatment, cumulus cells were removed and the metaphase I (MI) oocytes were collected for immunoblotting. Fifty oocytes were homogenized in a buffer containing 137 mM NaCl, 20 mM Tris-HCl, 1% Nonidet P40, 10% glycerol, 100 μg/ml phenylmethylsulphonylfluoride(PMSF), and 100 μg/ml leupeptin. Samples were boiled for 3 min, and separated by electrophoresis on 12% SDS-PAGE. Prestained SDS-polyacrylamide gel electrophoresis (PAGE) standards (Invitrogen) were used as molecular weight marker. They were then transferred onto nitrocellulose membranes (Protran; Schleicher & Schuell Bioscience, Dassel, Germany) pre-incubated for 1 h in blocking buffer containing 5% nonfat dry milk. The membranes were incubated with mouse anti-cyclin B1 monoclonal antibodies (Cell Signaling Technology, Danvers, MA, 1: 2000 dilution) at 4°C overnight. As control for loading, the membranes were also incubated with a rabbit anti-β-actin polyclonal antibody (sc-1616, Santa Cruz Biotechnology, CA) at a dilution of 1:1000. Goat anti-mouse IgG and goat anti-rabbit IgG (Zhongshan, Beijing, China) was used as the secondary antibody at a dilution of 1:2000. Blots were developed using chemiluminescent substrate from the detection system (ECL; Santa Cruz Biotechnology) and exposed to Kodak film. Exposed films were scanned on a GS 800 densitometer (Bio-Rad, Hercules, CA), and the intensity of signals was measured using Quantity One software (Bio-Rad).
In vitro maturation, fertilization, and early embryonic development
To assess the effect of KITL treatment on the cytoplasmic maturation of preovulatory oocytes, we performed in vitro maturation of oocytes followed by in vitro fertilization as described [7, 22]. COCs from PMSG-primed mice were obtained in M2 medium (Sigma) supplemented with 0.1% FBS before culturing in minimum essential media (Invitrogen) supplemented with Earle's salts, 10 μg/ml streptomycin sulfate, 75 μg/ml penicillin G, and 0.1% FBS in the presence or absence of 5 ng/ml KITL at 37 C in 5% CO2 95% air. After 16 h of treatment, cumulus cells were removed and oocytes were examined and classified according to their developmental stage (GV, MI, or MII). MII oocytes were inseminated with sperm (2–3 × 105/ml) from B6D2F1 males and incubated for 6 h at 37 C in 5% CO2 95% air. After in vitro fertilization, fertilized oocytes were recovered, washed twice, and cultured in IVF fertilization medium (COOK, Brisbane, Australia). Twenty-two hours after insemination, two-cell-stage embryos were collected and cultured in 50 μl drops of IVF cleavage medium (COOK) for 5 more days up to the blastocyst stage. Embryonic development was monitored daily under the Hoffman modulation contrast microscopy, and the development of preimplantation embryos was assessed.
Statistical analysis was carried out by using Mann-Whitney U test for paired comparison and the one way ANOVA followed Fisher's protected least significant difference for multiple group comparison. Results were considered to be significant at P < 0.05 for all tests. Each experiment was repeated at least three times and the results are presented as the mean ± SEM.
Gonadotropin stimulation of the ovarian expression of Kitl
Expression level of Kitl and c-kit transcripts in isolated ovarian cells and hCG stimulation of Kitl expression in granulosa cells
Localization of KITL antigen in ovary
Effects of KITL treatment on the nuclear maturation of preovulatory oocytes
We further assessed the molecular mechanism underlying the KITL promotion of first polar body extrusion. Because MI phase lasted between 7 and 10 h during in vitro culture in the oocytes, COCs obtained from preovulatory follicles were cultured for 7 h before measuring the levels of cyclin B1 proteins in oocytes at MI phase. Although cyclin B1 can be detected in all samples, its levels were increased 2.1-fold by treatment with KITL (Figure 4E).
Effects of KITL treatment on cytoplasmic maturation
The present study demonstrates increases of Kitl expression following the preovulatory LH/hCG surge in mouse ovaries. Using isolated ovarian cells, we further showed major increase of Kitl transcripts in granulosa cells, and predominant expression of c-kit in preovulatory oocytes. In in vitro cultures, KITL directly acts on preovulatory oocytes to stimulate first polar body extrusion, but not GVBD and cytoplasmic maturation.
Previous studies on the control of oocyte maturation have focused mainly on endocrine regulation of the hypothalamic-pituitary-ovarian axis. However, it has been recognized that intraovarian factors are also important in regulating oocyte maturation . The preovulatory LH surge triggers a cascade of events in ovarian follicles, including the resumption of meiotic maturation, luteinization, expansion or maturation of the cumulus cells, and follicle rupture. However, oocytes express few or no LH receptors and are insensitive to direct LH stimulation . Thus, the LH-responsive granulosa or theca cells could secret paracrine factors to regulate oocyte functions. To identify such intraovarian factors important for oocyte maturation, we performed DNA microarray analyses of the ovarian transcriptome during the peri-ovulatory period to provide a genome-wide screen of candidate genes. Here, we identified increases in the expression of Kitl mRNA after hCG stimulation in whole ovaries and isolated ovarian granulosa cells. Although Kitl mRNA was also increased in cumulus cells following hCG treatment, its level was lower than that of granulosa cells. Furthermore, KITL protein could be detected in granulosa, but not cumulus cells of preovulatory follicles obtained from ovaries of PMSG-primed mice at 4 h after hCG treatment. Granulosa cells in preantral and early antral follicles also expressed KITL, suggesting diverse role of KITL and c-kit throughout folliculogenesis and oogenesis, including the establishment of primordial germ cells within the ovary, primordial follicle activation, oocyte survival and growth, granulosa cell proliferation, theca cell recruitment, et al. The observed increases of Kitl mRNA in whole ovaries and granulosa cells are consistent with an earlier report using PMSG-primed rats at 6 h after hCG treatment . Likewise, low expression of Kitl was shown in cumulus cells of mouse antral follicles . Our findings of the predominant expression of c-kit mRNA in preovulatory oocytes are also consistent with earlier reports [8, 27, 28]. Because c-kit is also expressed in theca cells of antral follicles, corpora lutea, and some interstitial cells of the ovary , paracrine actions of KITL on the these cells cannot be ruled out.
Completion of the nuclear maturation of oocytes involves GVBD and extrusion of the first polar body. Although treatment of cultured COCs with KITL did not affect GVBD of preovulatory oocytes, it facilitated first polar body extrusion by 55% vs. control groups without treatment. This effect is comparable to that of another ovarian factor, IGF-I, showing 57% increases in first polar body extrusion vs. controls . The dose range of KITL used in the present studies was similar to that used in the rat study[26, 31]. Furthermore, the concentrations of KITL in human preovulatory follicular fluid were comparable to those levels. Similar to the BDNF stimulation of first polar body extrusion, but not GVBD, it is apparent that sequential steps of nuclear maturation of the oocyte are controlled by different paracrine factors. Although we detected transcripts of c-kit in both cumulus cells and oocytes in COCs, KITL induced first polar body extrusion in denuded oocytes, suggesting its direct effects on oocytes. Cyclin B is the regulatory subunit of maturation promoting factor, which induces meiotic resumption of immature mammalian oocytes. Mouse oocytes do not require de novo synthesis of proteins to undergo GVBD in vitro, whereas the synthesis of cyclin B1 is indispensable for the progression of meiotic maturation after GVBD. Rate of cyclin B1 synthesis controls the length of the first meiotic M phase. Our data on the increase in cyclin B1 protein in MI oocytes following KITL treatment suggest that cyclin B1 is involved in KITL promotion of completion of meiosis I.
Although a previous study reported that treatment of isolated preovulatory oocytes with KITL transiently blocked GVBD [26, 31], we did not observe an effect of KITL on GVBD of preovulatory oocytes using a follicle culture model. Because isolated oocytes undergo spontaneous GVBD after removal from surrounding somatic cells without LH treatment, our studies utilizing the preovulatory follicle model without spontaneous GVBD of the oocyte are more likely to reflect the in vivo conditions. Recent study demonstrated oocyte growth was limited in the absence of KITL, and yet spontaneous GVBD which could be inhibited by KITL2 was observed in these oocytes. The spontaneous GVBD is regarded as premature resumption of meiosis that reflects oocyte degeneration, rather than the physiologic meiosis . Their findings further supported our results. Our unpublished data further indicated that KITL treatment did not induce cumulus cell expansion in preovulatory follicles cultured with the serum-free medium. Mutant mice with defects in KITL or c-kit showed similar phenotypes including impairment of primordial germ cell survival, migration and proliferation, as well as defective follicle development . Because these mutant mice exhibit developmental arrest of follicles at primary stage, no female mice were available for investigating the roles of KITL/c-kit signaling in the preovulatory follicles. Thus, the roles of endogenous KITL in the oocyte maturation remain to be determined.
Some oocytes competent to complete nuclear maturation are unable to develop into blastocyst stage, which is indicative of deficient or defective cytoplasmic maturation of the oocyte . During the maturation process, oocytes undergo profound cytoplasmic changes which are essential for normal fertilization and embryonic development. However, treatment of preovulatory oocytes with KITL did not improve the developmental capacity of mouse oocytes. Our data is consistent with previous findings demonstrating that the concentrations of KITL in the human follicular fluid did not associate with the fertilization rate and pregnant outcome in patients undergoing intracytoplasmic sperm injection . Thus, the processes of nuclear and cytoplasmic maturation of the oocyte are independently regulated and could be controlled by different paracrine factors.
It has been demonstrated that there are significant interactions between oocyte secreted factors and KITL. Growth differentiation factor (GDF9) from oocyte has been shown to inhibit kitl expression in granulosa cells while present study demonstrates the enhancement of nuclear maturation by KITL produced by granulosa cells. And recent studies indicated an important role of GDF9 in promoting oocyte developmental potential [35–37]. These studies suggest that there are complex regulatory loops between oocytes and follicular somatic cells. Further study is needed to clarify the role of KITL and GDF9 interaction in oocyte nuclear and cytoplasmic maturation.
In the present study, we demonstrated increases of Kitl expression following LH/hCG stimulation in preovulatory granulosa cells and the ability of KITL to promote the first polar body extrusion of preovulatory oocytes. It is becoming clear that this ligand signaling system is important for diverse ovarian processes including primodial germ cell endowment, primordial follicle activation, theca cell recruitment, the antrum formation, and oocyte growth . The present demonstration of an augmenting role of KITL for the nuclear maturation of preovulatory oocytes underscores the importance of diverse paracrine systems for oocyte maturation. Understanding of these intercellular communication networks could lead to new approaches in the treatment of infertility, and facilitate future formulation of the optimal culture conditions for in vitro maturation and in vitro fertilization of oocytes.
This work was supported by a Grant-in-Aid for Scientific Research (K.K; Grant-in-Aid for Young Scientists B: 177911010 and 19791133, and T.T; Grant-in-Aid for Scientific Research B: 18390444) and the research funds from the Yamaguchi Endocrine Research Association (K.K.), the Kanae Foundation for Life and Socio-medical Science (K.K.) and the Kanzawa Medical Research Foundation (K.K.).
- Trounson A, Anderiesz C, Jones G: Maturation of human oocytes in vitro and their developmental competence. Reproduction. 2001, 121: 51-75. 10.1530/rep.0.1210051.View ArticlePubMed
- Fulka J, First NL, Moor RM: Nuclear and cytoplasmic determinants involved in the regulation of mammalian oocyte maturation. Mol Hum Reprod. 1998, 4: 41-49. 10.1093/molehr/4.1.41.View ArticlePubMed
- Eppig JJ: Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. Reprod Fertil Dev. 1996, 8: 485-489. 10.1071/RD9960485.View ArticlePubMed
- Eppig JJ, Downs SM: The effect of hypoxanthine on mouse oocyte growth and development in vitro: maintenance of meiotic arrest and gonadotropin-induced oocyte maturation. Dev Biol. 1987, 119: 313-321. 10.1016/0012-1606(87)90037-6.View ArticlePubMed
- Park J-Y, Su Y-Q, Ariga M, Law E, Jin SLC, Conti M: EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science. 2004, 303: 682-684. 10.1126/science.1092463.View ArticlePubMed
- Kawamura K, Kumagai J, Sudo S, Chun S-Y, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RAD, Hsueh AJW: Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA. 2004, 101: 7323-7328. 10.1073/pnas.0307061101.PubMed CentralView ArticlePubMed
- Kawamura K, Kawamura N, Mulders SM, Sollewijn Gelpke MD, Hsueh AJW: Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos. Proc Natl Acad Sci USA. 2005, 102: 9206-9211. 10.1073/pnas.0502442102.PubMed CentralView ArticlePubMed
- Hutt KJ, McLaughlin EA, Holland MK: Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Hum Reprod. 2006, 12: 61-69. 10.1093/molehr/gal010.View ArticlePubMed
- Liu K: Stem cell factor (SCF)-kit mediated phosphatidylinositol 3 (PI3) kinase signaling during mammalian oocyte growth and early follicular development. Front Biosci. 2006, 11: 126-135. 10.2741/1785.View ArticlePubMed
- Thomas FH, Ismail RS, Jiang JY, Vanderhyden BC: Kit ligand 2 promotes murine oocyte growth in vitro. Biol Reprod. 2008, 78: 167-175. 10.1095/biolreprod.106.058529.View ArticlePubMed
- Moniruzzaman M, Miyano T: KIT-KIT ligand in the growth of porcine oocytes in primordial follicles. J Reprod Dev. 2007, 53: 1273-1281. 10.1262/jrd.19107.View ArticlePubMed
- Hutt KJ, McLaughlin EA, Holland MK: KIT/KIT ligand in mammalian oogenesis and folliculogenesis: roles in rabbit and murine ovarian follicle activation and oocyte growth. Biol Reprod. 2006, 75: 421-433. 10.1095/biolreprod.106.051516.View ArticlePubMed
- Klinger FG, De Felici M: In vitro development of growing oocytes from fetal mouse oocytes: stage-specific regulation by stem cell factor and granulosa cells. Dev Biol. 2002, 244: 85-95. 10.1006/dbio.2002.0592.View ArticlePubMed
- Reynaud K, Cortvrindt R, Smitz J, Driancourt MA: Effects of Kit Ligand and anti-Kit antibody on growth of cultured mouse preantral follicles. Mol Reprod Dev. 2000, 56: 483-494. 10.1002/1098-2795(200008)56:4<483::AID-MRD6>3.0.CO;2-O.View ArticlePubMed
- Liu L, Rajareddy S, Reddy P, Jagarlamudi K, Du C, Shen Y, Guo Y, Boman K, Lundin E, Ottander U, Selstam G, Liu K: Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development. J Mol Endocrinol. 2007, 38: 137-146. 10.1677/jme.1.02027.View ArticlePubMed
- Liu K, Rajareddy S, Liu L, Jagarlamudi K, Boman K, Selstam G, Reddy P: Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: new roles for an old timer. Dev Biol. 2006, 299: 1-11. 10.1016/j.ydbio.2006.07.038.View ArticlePubMed
- Thomas FH, Vanderhyden BC: Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol. 2006, 4: 19-19. 10.1186/1477-7827-4-19.PubMed CentralView ArticlePubMed
- Brankin V, Mitchell MRP, Webb B, Hunter MG: Paracrine effects of oocyte secreted factors and stem cell factor on porcine granulosa and theca cells in vitro. Reprod Biol Endocrinol. 2003, 1: 55-55. 10.1186/1477-7827-1-55.PubMed CentralView ArticlePubMed
- Jin X, Han C-S, Zhang X-S, Yu F-Q, Guo S-H, Hu Z-Y, Liu Y-X: Stem cell factor modulates the expression of steroidogenesis related proteins and FSHR during ovarian follicular development. Front Biosci. 2005, 10: 1573-1580. 10.2741/1641.View ArticlePubMed
- Sharov AA, Li GZ, Palkina TN, Sharova TY, Gilchrest BA, Botchkarev VA: Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol. 2003, 120: 27-35. 10.1046/j.1523-1747.2003.12022.x.View ArticlePubMed
- Hammadeh ME, Fischer-Hammadeh C, Hoffmeister H, Herrmann W, Rosenbaum P, Schmidt W: Relationship between cytokine concentrations (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome. Am J Reprod Immunol. 2004, 51: 81-85. 10.1046/j.8755-8920.2003.00121.x.View ArticlePubMed
- Marin Bivens CL, Grondahl C, Murray A, Blume T, Su Y-Q, Eppig JJ: Meiosis-activating sterol promotes the metaphase I to metaphase II transition and preimplantation developmental competence of mouse oocytes maturing in vitro. Biol Reprod. 2004, 70: 1458-1464. 10.1095/biolreprod.103.026351.View ArticlePubMed
- Kawamura K, Ye Y, Kawamura N, Jing L, Groenen P, Gelpke MS, Rauch R, Hsueh AJ, Tanaka T: Completion of Meiosis I of preovulatory oocytes and facilitation of preimplantation embryo development by glial cell line-derived neurotrophic factor. Dev Biol. 2008, 315: 189-202. 10.1016/j.ydbio.2007.12.029.View ArticlePubMed
- Ben-Ami I, Freimann S, Armon L, Dantes A, Ron-El R, Amsterdam A: Novel function of ovarian growth factors: combined studies by DNA microarray, biochemical and physiological approaches. Mol Hum Reprod. 2006, 12: 413-419. 10.1093/molehr/gal045.View ArticlePubMed
- Peng XR, Hsueh AJ, LaPolt PS, Bjersing L, Ny T: Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology. 1991, 129: 3200-3207.View ArticlePubMed
- Ismail RS, Okawara Y, Fryer JN, Vanderhyden BC: Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation. Mol Reprod Dev. 1996, 43: 458-469. 10.1002/(SICI)1098-2795(199604)43:4<458::AID-MRD8>3.0.CO;2-O.View ArticlePubMed
- Driancourt MA, Reynaud K, Cortvrindt R, Smitz J: Roles of KIT and KIT LIGAND in ovarian function. Rev Reprod. 2000, 5: 143-152. 10.1530/ror.0.0050143.View ArticlePubMed
- Abir R, Fisch B, Jin S, Barnnet M, Kessler-Icekson G, Ao A: Expression of stem cell factor and its receptor in human fetal and adult ovaries. Fertil Steril. 2004, 82 (Suppl 3): 1235-1243. 10.1016/j.fertnstert.2004.02.146.View ArticlePubMed
- Silva JR, van den Hurk R, van Tol HT, Roelen BA, Figueiredo JR: The Kit ligand/c-Kit receptor system in goat ovaries: gene expression and protein localization. Zygote. 2006, 14: 317-328. 10.1017/S0967199406003832.View ArticlePubMed
- Kiapekou E, Loutradis D, Drakakis P, Zapanti E, Mastorakos G, Antsaklis A: Effects of GH and IGF-I on the in vitro maturation of mouse oocytes. Hormones (Athens, Greece). 2005, 4: 155-160.View Article
- Ismail RS, Dube M, Vanderhyden BC: Hormonally regulated expression and alternative splicing of kit ligand may regulate kit-induced inhibition of meiosis in rat oocytes. Dev Biol. 1997, 184: 333-342. 10.1006/dbio.1997.8531.View ArticlePubMed
- Sugiura K, Naito K, Endo T, Tojo H: Study of germinal vesicle requirement for the normal kinetics of maturation/M-phase-promoting factor activity during porcine oocyte maturation. Biol Reprod. 2006, 74: 593-600. 10.1095/biolreprod.105.046375.View ArticlePubMed
- Polanski Z, Ledan E, Brunet S, Louvet S, Verlhac MH, Kubiak JZ, Maro B: Cyclin synthesis controls the progression of meiotic maturation in mouse oocytes. Development. 1998, 125: 4989-4997.PubMed
- Joyce IMCA, Pendola FL, Eppig JJ: Comparison of recombinant growth differentiation factor-9 and oocyte regulation of KIT ligand messenger ribonucleic acid expression in mouse ovarian follicles. Biol Reprod. 2000, 63: 1669-1672. 10.1095/biolreprod63.6.1669.View ArticlePubMed
- Gilchrist RB, Lane M, Thompson JG: Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update. 2008, 14: 159-177. 10.1093/humupd/dmm040.View ArticlePubMed
- Yeo CX, Gilchrist RB, Thompson JG, Lane M: Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice. Hum Reprod. 2008, 23: 67-73. 10.1093/humrep/dem140.View ArticlePubMed
- Hussein TS, Thompson JG, Gilchrist RB: Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol. 2006, 296: 514-521. 10.1016/j.ydbio.2006.06.026.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.